| Code | Description | Claims | Beneficiaries | Total Paid |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,070 |
2,210 |
$4.41M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,184 |
8,119 |
$2.97M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,576 |
3,661 |
$2.80M |
| J3490 |
Unclassified drugs |
2,067 |
1,158 |
$2.66M |
| 80053 |
Comprehensive metabolic panel |
29,921 |
25,103 |
$2.01M |
| 36415 |
Collection of venous blood by venipuncture |
22,484 |
18,175 |
$1.84M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,275 |
24,767 |
$1.61M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,991 |
13,076 |
$1.14M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17,228 |
14,740 |
$1.02M |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
504 |
490 |
$930K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,559 |
5,611 |
$786K |
| 81001 |
|
12,579 |
11,366 |
$766K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
945 |
554 |
$706K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,905 |
4,380 |
$692K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
3,233 |
3,045 |
$654K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,423 |
4,138 |
$590K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,768 |
2,742 |
$554K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,796 |
2,379 |
$512K |
| 81003 |
|
11,555 |
10,686 |
$480K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,884 |
3,515 |
$474K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,264 |
11,073 |
$434K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,503 |
22,835 |
$355K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,258 |
4,935 |
$297K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,853 |
1,579 |
$289K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,232 |
5,684 |
$287K |
| 96402 |
|
688 |
591 |
$280K |
| 81025 |
|
10,062 |
9,371 |
$270K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,189 |
6,827 |
$250K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
580 |
547 |
$226K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,045 |
5,610 |
$202K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,246 |
1,188 |
$200K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,394 |
3,033 |
$189K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,208 |
3,528 |
$175K |
| 86901 |
|
4,066 |
3,616 |
$167K |
| 93971 |
|
1,210 |
1,151 |
$165K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,040 |
937 |
$159K |
| 87210 |
|
1,526 |
1,340 |
$141K |
| 84702 |
|
3,572 |
2,809 |
$141K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,597 |
4,317 |
$137K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
148 |
146 |
$133K |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
391 |
201 |
$129K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,488 |
2,773 |
$124K |
| 71250 |
|
737 |
699 |
$122K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,873 |
1,805 |
$120K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
168 |
162 |
$119K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
749 |
720 |
$117K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
35,433 |
28,938 |
$110K |
| 87430 |
|
1,903 |
1,799 |
$105K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,306 |
11,841 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,968 |
1,831 |
$103K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,173 |
2,104 |
$102K |
| 85027 |
|
17,503 |
15,168 |
$101K |
| 59025 |
Fetal non-stress test |
2,315 |
1,925 |
$99K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,688 |
1,603 |
$95K |
| 71046 |
Radiologic examination, chest; 2 views |
5,435 |
5,123 |
$95K |
| A9609 |
Fludeoxyglucose f18 up to 15 millicuries |
125 |
111 |
$91K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,543 |
1,459 |
$82K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,576 |
2,249 |
$79K |
| 71045 |
Radiologic examination, chest; single view |
7,598 |
6,859 |
$78K |
| 73630 |
|
1,013 |
961 |
$72K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,517 |
4,038 |
$66K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,557 |
1,470 |
$66K |
| 72100 |
|
1,492 |
1,428 |
$58K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,030 |
2,351 |
$56K |
| 73562 |
|
803 |
732 |
$53K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
644 |
614 |
$51K |
| 73610 |
|
638 |
610 |
$48K |
| 73030 |
|
926 |
884 |
$48K |
| 84484 |
|
8,497 |
6,955 |
$47K |
| 87040 |
|
2,456 |
1,827 |
$45K |
| 72141 |
|
68 |
65 |
$44K |
| 87428 |
|
209 |
204 |
$42K |
| 82728 |
|
3,031 |
2,838 |
$39K |
| 76830 |
Ultrasound, transvaginal |
869 |
827 |
$37K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,595 |
3,387 |
$35K |
| 62323 |
|
556 |
519 |
$32K |
| 86850 |
|
2,701 |
2,380 |
$32K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
788 |
757 |
$29K |
| 80076 |
|
3,411 |
3,206 |
$29K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,439 |
1,694 |
$28K |
| 84132 |
|
894 |
817 |
$27K |
| 72050 |
|
331 |
328 |
$26K |
| 96401 |
|
68 |
26 |
$25K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
681 |
657 |
$25K |
| 76825 |
|
236 |
228 |
$25K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
644 |
592 |
$24K |
| 73221 |
|
38 |
37 |
$23K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
495 |
432 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,508 |
11,075 |
$22K |
| 82607 |
|
1,441 |
1,346 |
$21K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
436 |
407 |
$21K |
| 77300 |
|
13 |
12 |
$21K |
| G0378 |
Hospital observation service, per hour |
3,910 |
2,459 |
$21K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
685 |
366 |
$21K |
| 84439 |
|
1,935 |
1,826 |
$20K |
| 76642 |
|
539 |
476 |
$19K |
| 76820 |
|
1,899 |
891 |
$19K |
| 77066 |
Tomosynthesis, mammo |
168 |
159 |
$18K |
| 96367 |
|
2,528 |
1,543 |
$18K |
| 73130 |
|
239 |
226 |
$18K |
| 96376 |
|
3,617 |
2,736 |
$18K |
| 85610 |
|
3,395 |
2,885 |
$16K |
| 73502 |
|
463 |
438 |
$16K |
| 84112 |
|
47 |
46 |
$15K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
233 |
207 |
$14K |
| 84703 |
|
224 |
210 |
$13K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
118 |
103 |
$13K |
| 73560 |
|
350 |
341 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,541 |
5,205 |
$11K |
| 76536 |
|
123 |
118 |
$10K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
152 |
150 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
417 |
341 |
$10K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
785 |
731 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,005 |
1,889 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,029 |
1,912 |
$9K |
| 77336 |
|
69 |
27 |
$9K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
132 |
125 |
$9K |
| 97161 |
|
954 |
890 |
$8K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,925 |
921 |
$8K |
| 93976 |
|
405 |
384 |
$8K |
| C1769 |
Guide wire |
61 |
57 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,856 |
1,790 |
$8K |
| 73110 |
|
116 |
107 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
43 |
41 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
44 |
39 |
$7K |
| 86900 |
|
3,887 |
3,454 |
$7K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
12 |
$6K |
| 82570 |
|
1,677 |
1,468 |
$6K |
| 84156 |
|
1,548 |
1,280 |
$6K |
| 83605 |
|
4,624 |
4,031 |
$5K |
| 87077 |
|
1,839 |
1,667 |
$5K |
| A9270 |
Non-covered item or service |
5,691 |
4,265 |
$5K |
| 93970 |
|
25 |
25 |
$5K |
| 74019 |
|
314 |
304 |
$5K |
| 80061 |
Lipid panel |
2,854 |
2,751 |
$5K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
186 |
128 |
$5K |
| 0240U |
|
28 |
28 |
$4K |
| 83735 |
|
4,663 |
3,822 |
$4K |
| 85379 |
|
2,286 |
2,133 |
$3K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$3K |
| 86592 |
|
872 |
810 |
$3K |
| 82746 |
|
959 |
888 |
$3K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
13 |
12 |
$3K |
| 74018 |
|
116 |
108 |
$2K |
| 77065 |
Tomosynthesis, mammo |
43 |
37 |
$2K |
| 96523 |
|
100 |
81 |
$2K |
| 87807 |
|
196 |
189 |
$2K |
| 82950 |
|
756 |
743 |
$2K |
| 82378 |
|
495 |
379 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
41 |
40 |
$2K |
| 83880 |
|
2,785 |
2,474 |
$2K |
| 83520 |
|
791 |
731 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
672 |
568 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
38 |
34 |
$1K |
| 88304 |
|
98 |
96 |
$1K |
| 83021 |
|
159 |
145 |
$1K |
| 12001 |
|
14 |
13 |
$1K |
| 72072 |
|
25 |
25 |
$1K |
| 86140 |
|
603 |
521 |
$1K |
| 97162 |
|
103 |
98 |
$979.48 |
| 87486 |
|
12 |
12 |
$964.33 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
186 |
100 |
$962.90 |
| 82105 |
|
220 |
212 |
$899.10 |
| 36430 |
|
129 |
98 |
$873.98 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
103 |
24 |
$772.15 |
| 82784 |
|
84 |
72 |
$638.15 |
| 83690 |
|
9,055 |
8,104 |
$525.49 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
874 |
639 |
$521.22 |
| 84153 |
|
125 |
106 |
$505.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,020 |
2,567 |
$495.65 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,075 |
3,168 |
$480.50 |
| 86803 |
|
247 |
229 |
$434.41 |
| J1756 |
Injection, iron sucrose, 1 mg |
1,462 |
684 |
$413.91 |
| 82550 |
|
1,689 |
1,563 |
$383.32 |
| 86300 |
|
90 |
77 |
$353.44 |
| 96415 |
|
1,833 |
1,146 |
$321.67 |
| 83540 |
|
1,904 |
1,772 |
$294.19 |
| 83615 |
|
624 |
541 |
$287.09 |
| 76821 |
|
343 |
179 |
$272.34 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,599 |
1,505 |
$204.70 |
| 85045 |
|
804 |
737 |
$196.98 |
| 86780 |
|
119 |
110 |
$163.57 |
| 84165 |
|
72 |
68 |
$149.75 |
| 83550 |
|
1,807 |
1,682 |
$140.22 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
209 |
196 |
$129.48 |
| 87070 |
|
74 |
65 |
$121.06 |
| 0098U |
|
21 |
19 |
$115.45 |
| 96368 |
|
842 |
488 |
$105.34 |
| 97165 |
|
50 |
48 |
$92.21 |
| 90686 |
|
42 |
39 |
$59.01 |
| 85652 |
|
334 |
316 |
$54.42 |
| 83970 |
|
12 |
12 |
$54.27 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
153 |
130 |
$42.21 |
| J2704 |
Injection, propofol, 10 mg |
2,396 |
1,351 |
$38.81 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,717 |
1,093 |
$32.94 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
591 |
565 |
$32.08 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
68 |
55 |
$31.79 |
| 85018 |
|
106 |
90 |
$25.62 |
| 85730 |
|
1,081 |
1,024 |
$15.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,020 |
2,652 |
$12.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
734 |
615 |
$10.98 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,262 |
1,041 |
$10.98 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
696 |
571 |
$10.76 |
| 84100 |
|
347 |
262 |
$2.71 |
| J1940 |
Injection, furosemide, up to 20 mg |
35 |
26 |
$1.47 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,075 |
1,069 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,172 |
1,066 |
$0.00 |
| 87340 |
|
1,099 |
1,019 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
379 |
351 |
$0.00 |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
480 |
316 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
78 |
75 |
$0.00 |
| 96411 |
|
474 |
261 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
164 |
158 |
$0.00 |
| 86762 |
|
478 |
433 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
463 |
379 |
$0.00 |
| 88342 |
|
280 |
263 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
385 |
188 |
$0.00 |
| 86706 |
|
13 |
13 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
198 |
107 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,353 |
1,274 |
$0.00 |
| 88307 |
|
72 |
65 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
290 |
273 |
$0.00 |
| 82803 |
|
61 |
53 |
$0.00 |
| 86747 |
|
336 |
309 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
26 |
24 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
198 |
180 |
$0.00 |
| 85660 |
|
172 |
158 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
99 |
53 |
$0.00 |
| J0185 |
Injection, aprepitant, 1 mg |
33 |
24 |
$0.00 |
| 86920 |
|
163 |
121 |
$0.00 |
| J9395 |
Injection, fulvestrant, 25 mg |
18 |
12 |
$0.00 |
| 82043 |
|
13 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
21 |
16 |
$0.00 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
31 |
25 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
34 |
32 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
31 |
30 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
27 |
12 |
$0.00 |
| 87205 |
|
29 |
25 |
$0.00 |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
16 |
12 |
$0.00 |
| 82677 |
|
13 |
13 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
12 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
32 |
25 |
$0.00 |
| 87581 |
|
12 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
13 |
13 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
119 |
84 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
33 |
30 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
992 |
264 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
121 |
95 |
$0.00 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
679 |
662 |
$0.00 |
| J9271 |
Injection, pembrolizumab, 1 mg |
675 |
467 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
206 |
198 |
$0.00 |
| 87186 |
|
827 |
773 |
$0.00 |
| 84145 |
|
696 |
627 |
$0.00 |
| 90715 |
|
165 |
158 |
$0.00 |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
268 |
197 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
242 |
195 |
$0.00 |
| 96417 |
|
1,582 |
912 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
17 |
14 |
$0.00 |
| J0897 |
Injection, denosumab, 1 mg |
166 |
142 |
$0.00 |
| J9206 |
Injection, irinotecan, 20 mg |
299 |
77 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
352 |
236 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
92 |
85 |
$0.00 |
| 93017 |
|
13 |
13 |
$0.00 |
| 86787 |
|
129 |
121 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
997 |
345 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
99 |
78 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
341 |
95 |
$0.00 |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,067 |
613 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
175 |
138 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
102 |
100 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
72 |
55 |
$0.00 |
| 84550 |
|
15 |
13 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
36 |
32 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
68 |
49 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
14 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
13 |
12 |
$0.00 |
| 86336 |
|
13 |
13 |
$0.00 |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
76 |
25 |
$0.00 |
| 82947 |
|
12 |
12 |
$0.00 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
17 |
16 |
$0.00 |
| A4641 |
Radiopharmaceutical, diagnostic, not otherwise classified |
15 |
15 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
12 |
12 |
$0.00 |